Natixis Advisors’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-10,884
Closed -$2.31M 1084
2014
Q4
$2.31M Sell
10,884
-12,279
-53% -$2.44M 0.04% 557
2014
Q3
$4.13M Buy
23,163
+10,561
+84% +$1.75M 0.08% 369
2014
Q2
$2.13M Buy
12,602
+1,901
+18% +$296K 0.03% 644
2014
Q1
$1.33M Sell
10,701
-30,096
-74% -$3.66M 0.02% 706
2013
Q4
$4.53M Buy
40,797
+32,825
+412% +$3.14M 0.07% 422
2013
Q3
$721K Buy
7,972
+372
+5% +$33.4K 0.01% 759
2013
Q2
$640K Buy
+7,600
New +$788K 0.01% 764

Other funds holding AGN

Natixis Advisors's AGN Position: Q1 2015 in Review

Natixis Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 10,884 shares — an estimated $2.31M sold.

Natixis Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $4.53M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Natixis Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Natixis Advisors sold 10,884 Allergan Inc shares in Q1 2015, an estimated $2.31M.
  • Natixis Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Natixis Advisors's Allergan Inc position peaked at $4.53M in Q4 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Natixis Advisors's 13F filing for Q1 2015, filed 15 May 2015.